Metabolomic analysis of synovial fluid from Thoroughbred racehorses diagnosed with palmar osteochondral disease using magnetic resonance imaging

Summary Background Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Equine veterinary journal 2020-05, Vol.52 (3), p.384-390
Hauptverfasser: Graham, R. J. T. Y., Anderson, J. R., Phelan, M. M., Cillan‐Garcia, E., Bladon, B. M., Taylor, S. E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 390
container_issue 3
container_start_page 384
container_title Equine veterinary journal
container_volume 52
creator Graham, R. J. T. Y.
Anderson, J. R.
Phelan, M. M.
Cillan‐Garcia, E.
Bladon, B. M.
Taylor, S. E.
description Summary Background Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There is increasing interest in the use of metabolomics for diagnosis prior to progression to irreversible damage. Objectives To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between diseased and healthy joints. Study design Prospective clinical study. Methods Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using 1H‐nuclear magnetic resonance (NMR) spectroscopy and analysed. Results Twenty‐five metabolites were recognised associated with various biosynthetic and degradation pathways. The metabolite abundances within the controls demonstrated increased variability compared with the clinical group. The low level of variance between the spectra of the two groups was explained by five principal components. Cross‐validation of the cohort demonstrated modest separation of predictive power (R2 = 0.67; Q2 = 0.34). Although statistical significance was not achieved, the most influential metabolites were glucose and lactate. Main limitations The modest sample size and variation in signalment, background and presenting condition of the controls may have impacted the discriminative power of the constructed models. The lack of matched controls, differences in time of fluid collection and freezing times may have also reduced accuracy when representing metabolite profiles. Conclusions This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with POD.
doi_str_mv 10.1111/evj.13199
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2386947433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2386947433</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3889-e2b4763f8dd2fafa26073f5e67e416f4dee04af6dbdf01f8183739592177e3193</originalsourceid><addsrcrecordid>eNqNkc9u1DAQxi0EokvhwAsgS1xAaFv_i5Mcq1VpQUVcCtfIice7XiXx4kla7VvwyEzZpQckJHzxePz7xuP5GHstxZmkdQ532zOpZV0_YQsljFpqLexTtqCwWEprzAl7gbgVQmtl1HN2oqUtSlGKBfv5BSbXpj4NseNudP0eI_IUOO7HdBddz0M_R89DTgO_3aSc5vWmzeB5dh3QGQG5j249JqTkfZw2fOf6wWWecILUbdLoM5XxEcEh8BnjuOYDCWCiJzNgGt3YAY-Uo6uX7FlwPcKr437Kvn28vF1dL2--Xn1aXdwsO11V9RJUa0qrQ-W9Ci44ZUWpQwG2BCNtMB5AGBesb30QMlSy0qWui1rJsgQalT5l7w51dzn9mAGnZojYQd-7EdKMjdKiroQqhCH07V_oNs2ZZvVAVbY2pdGaqPcHqssJMUNodpn-lPeNFM2DTQ3Z1Py2idg3x4pzO4B_JP_4QsCHA3APbQrYRaARPWJCiELpWlhNkVREV_9Pr-LkppjGVZrHiaTnR2nsYf_vlpvL758Pvf8CGqW_yQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2386947433</pqid></control><display><type>article</type><title>Metabolomic analysis of synovial fluid from Thoroughbred racehorses diagnosed with palmar osteochondral disease using magnetic resonance imaging</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Web of Science - Science Citation Index Expanded - 2020&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><creator>Graham, R. J. T. Y. ; Anderson, J. R. ; Phelan, M. M. ; Cillan‐Garcia, E. ; Bladon, B. M. ; Taylor, S. E.</creator><creatorcontrib>Graham, R. J. T. Y. ; Anderson, J. R. ; Phelan, M. M. ; Cillan‐Garcia, E. ; Bladon, B. M. ; Taylor, S. E.</creatorcontrib><description>Summary Background Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There is increasing interest in the use of metabolomics for diagnosis prior to progression to irreversible damage. Objectives To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between diseased and healthy joints. Study design Prospective clinical study. Methods Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using 1H‐nuclear magnetic resonance (NMR) spectroscopy and analysed. Results Twenty‐five metabolites were recognised associated with various biosynthetic and degradation pathways. The metabolite abundances within the controls demonstrated increased variability compared with the clinical group. The low level of variance between the spectra of the two groups was explained by five principal components. Cross‐validation of the cohort demonstrated modest separation of predictive power (R2 = 0.67; Q2 = 0.34). Although statistical significance was not achieved, the most influential metabolites were glucose and lactate. Main limitations The modest sample size and variation in signalment, background and presenting condition of the controls may have impacted the discriminative power of the constructed models. The lack of matched controls, differences in time of fluid collection and freezing times may have also reduced accuracy when representing metabolite profiles. Conclusions This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with POD.</description><identifier>ISSN: 0425-1644</identifier><identifier>EISSN: 2042-3306</identifier><identifier>DOI: 10.1111/evj.13199</identifier><identifier>PMID: 31657070</identifier><language>eng</language><publisher>HOBOKEN: Wiley</publisher><subject>Animals ; horse ; Horse Diseases ; Horses ; Life Sciences &amp; Biomedicine ; Magnetic Resonance Imaging ; Metabolites ; Metabolomics ; metacarpophalangeal joint ; NMR ; Nuclear magnetic resonance ; palmar osteochondral disease ; Prospective Studies ; Science &amp; Technology ; Spectrum analysis ; Synovial Fluid ; Veterinary Sciences</subject><ispartof>Equine veterinary journal, 2020-05, Vol.52 (3), p.384-390</ispartof><rights>2019 EVJ Ltd</rights><rights>2019 EVJ Ltd.</rights><rights>Copyright © 2020 EVJ Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000523906300012</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c3889-e2b4763f8dd2fafa26073f5e67e416f4dee04af6dbdf01f8183739592177e3193</citedby><cites>FETCH-LOGICAL-c3889-e2b4763f8dd2fafa26073f5e67e416f4dee04af6dbdf01f8183739592177e3193</cites><orcidid>0000-0001-9204-725X ; 0000-0002-7561-0570 ; 0000-0003-0489-7997 ; 0000-0002-8840-4098</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fevj.13199$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fevj.13199$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27933,27934,28257,45583,45584</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31657070$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Graham, R. J. T. Y.</creatorcontrib><creatorcontrib>Anderson, J. R.</creatorcontrib><creatorcontrib>Phelan, M. M.</creatorcontrib><creatorcontrib>Cillan‐Garcia, E.</creatorcontrib><creatorcontrib>Bladon, B. M.</creatorcontrib><creatorcontrib>Taylor, S. E.</creatorcontrib><title>Metabolomic analysis of synovial fluid from Thoroughbred racehorses diagnosed with palmar osteochondral disease using magnetic resonance imaging</title><title>Equine veterinary journal</title><addtitle>EQUINE VET J</addtitle><addtitle>Equine Vet J</addtitle><description>Summary Background Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There is increasing interest in the use of metabolomics for diagnosis prior to progression to irreversible damage. Objectives To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between diseased and healthy joints. Study design Prospective clinical study. Methods Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using 1H‐nuclear magnetic resonance (NMR) spectroscopy and analysed. Results Twenty‐five metabolites were recognised associated with various biosynthetic and degradation pathways. The metabolite abundances within the controls demonstrated increased variability compared with the clinical group. The low level of variance between the spectra of the two groups was explained by five principal components. Cross‐validation of the cohort demonstrated modest separation of predictive power (R2 = 0.67; Q2 = 0.34). Although statistical significance was not achieved, the most influential metabolites were glucose and lactate. Main limitations The modest sample size and variation in signalment, background and presenting condition of the controls may have impacted the discriminative power of the constructed models. The lack of matched controls, differences in time of fluid collection and freezing times may have also reduced accuracy when representing metabolite profiles. Conclusions This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with POD.</description><subject>Animals</subject><subject>horse</subject><subject>Horse Diseases</subject><subject>Horses</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Magnetic Resonance Imaging</subject><subject>Metabolites</subject><subject>Metabolomics</subject><subject>metacarpophalangeal joint</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>palmar osteochondral disease</subject><subject>Prospective Studies</subject><subject>Science &amp; Technology</subject><subject>Spectrum analysis</subject><subject>Synovial Fluid</subject><subject>Veterinary Sciences</subject><issn>0425-1644</issn><issn>2042-3306</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><sourceid>EIF</sourceid><recordid>eNqNkc9u1DAQxi0EokvhwAsgS1xAaFv_i5Mcq1VpQUVcCtfIice7XiXx4kla7VvwyEzZpQckJHzxePz7xuP5GHstxZmkdQ532zOpZV0_YQsljFpqLexTtqCwWEprzAl7gbgVQmtl1HN2oqUtSlGKBfv5BSbXpj4NseNudP0eI_IUOO7HdBddz0M_R89DTgO_3aSc5vWmzeB5dh3QGQG5j249JqTkfZw2fOf6wWWecILUbdLoM5XxEcEh8BnjuOYDCWCiJzNgGt3YAY-Uo6uX7FlwPcKr437Kvn28vF1dL2--Xn1aXdwsO11V9RJUa0qrQ-W9Ci44ZUWpQwG2BCNtMB5AGBesb30QMlSy0qWui1rJsgQalT5l7w51dzn9mAGnZojYQd-7EdKMjdKiroQqhCH07V_oNs2ZZvVAVbY2pdGaqPcHqssJMUNodpn-lPeNFM2DTQ3Z1Py2idg3x4pzO4B_JP_4QsCHA3APbQrYRaARPWJCiELpWlhNkVREV_9Pr-LkppjGVZrHiaTnR2nsYf_vlpvL758Pvf8CGqW_yQ</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Graham, R. J. T. Y.</creator><creator>Anderson, J. R.</creator><creator>Phelan, M. M.</creator><creator>Cillan‐Garcia, E.</creator><creator>Bladon, B. M.</creator><creator>Taylor, S. E.</creator><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9204-725X</orcidid><orcidid>https://orcid.org/0000-0002-7561-0570</orcidid><orcidid>https://orcid.org/0000-0003-0489-7997</orcidid><orcidid>https://orcid.org/0000-0002-8840-4098</orcidid></search><sort><creationdate>202005</creationdate><title>Metabolomic analysis of synovial fluid from Thoroughbred racehorses diagnosed with palmar osteochondral disease using magnetic resonance imaging</title><author>Graham, R. J. T. Y. ; Anderson, J. R. ; Phelan, M. M. ; Cillan‐Garcia, E. ; Bladon, B. M. ; Taylor, S. E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3889-e2b4763f8dd2fafa26073f5e67e416f4dee04af6dbdf01f8183739592177e3193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>horse</topic><topic>Horse Diseases</topic><topic>Horses</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Magnetic Resonance Imaging</topic><topic>Metabolites</topic><topic>Metabolomics</topic><topic>metacarpophalangeal joint</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>palmar osteochondral disease</topic><topic>Prospective Studies</topic><topic>Science &amp; Technology</topic><topic>Spectrum analysis</topic><topic>Synovial Fluid</topic><topic>Veterinary Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Graham, R. J. T. Y.</creatorcontrib><creatorcontrib>Anderson, J. R.</creatorcontrib><creatorcontrib>Phelan, M. M.</creatorcontrib><creatorcontrib>Cillan‐Garcia, E.</creatorcontrib><creatorcontrib>Bladon, B. M.</creatorcontrib><creatorcontrib>Taylor, S. E.</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Equine veterinary journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Graham, R. J. T. Y.</au><au>Anderson, J. R.</au><au>Phelan, M. M.</au><au>Cillan‐Garcia, E.</au><au>Bladon, B. M.</au><au>Taylor, S. E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolomic analysis of synovial fluid from Thoroughbred racehorses diagnosed with palmar osteochondral disease using magnetic resonance imaging</atitle><jtitle>Equine veterinary journal</jtitle><stitle>EQUINE VET J</stitle><addtitle>Equine Vet J</addtitle><date>2020-05</date><risdate>2020</risdate><volume>52</volume><issue>3</issue><spage>384</spage><epage>390</epage><pages>384-390</pages><issn>0425-1644</issn><eissn>2042-3306</eissn><abstract>Summary Background Palmar osteochondral disease (POD) is a common cause of lameness in competition horses. Magnetic resonance imaging (MRI) is the most sensitive diagnostic modality currently available, however it may not be financially or logistically practical for routine screening of POD. There is increasing interest in the use of metabolomics for diagnosis prior to progression to irreversible damage. Objectives To determine metabolite levels in synovial fluid (SF) of horses with a clinical diagnosis of POD based on diagnostic analgesia and MRI, with the hypothesis that metabolomic profiles differ between diseased and healthy joints. Study design Prospective clinical study. Methods Synovial fluid was collected from metacarpo/tarsophalangeal joints (MC/TPJ) of 29 horses (n = 51 joints), including 14 controls (n = 26) and 15 cases (n = 25), the latter with lameness localised to the MC/TPJ and MR changes consistent with POD (n = 23). Spectra were produced using 1H‐nuclear magnetic resonance (NMR) spectroscopy and analysed. Results Twenty‐five metabolites were recognised associated with various biosynthetic and degradation pathways. The metabolite abundances within the controls demonstrated increased variability compared with the clinical group. The low level of variance between the spectra of the two groups was explained by five principal components. Cross‐validation of the cohort demonstrated modest separation of predictive power (R2 = 0.67; Q2 = 0.34). Although statistical significance was not achieved, the most influential metabolites were glucose and lactate. Main limitations The modest sample size and variation in signalment, background and presenting condition of the controls may have impacted the discriminative power of the constructed models. The lack of matched controls, differences in time of fluid collection and freezing times may have also reduced accuracy when representing metabolite profiles. Conclusions This study identified and quantified metabolites present in MC/TPJ SF of clinical cases with POD.</abstract><cop>HOBOKEN</cop><pub>Wiley</pub><pmid>31657070</pmid><doi>10.1111/evj.13199</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-9204-725X</orcidid><orcidid>https://orcid.org/0000-0002-7561-0570</orcidid><orcidid>https://orcid.org/0000-0003-0489-7997</orcidid><orcidid>https://orcid.org/0000-0002-8840-4098</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0425-1644
ispartof Equine veterinary journal, 2020-05, Vol.52 (3), p.384-390
issn 0425-1644
2042-3306
language eng
recordid cdi_proquest_journals_2386947433
source MEDLINE; Access via Wiley Online Library; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />
subjects Animals
horse
Horse Diseases
Horses
Life Sciences & Biomedicine
Magnetic Resonance Imaging
Metabolites
Metabolomics
metacarpophalangeal joint
NMR
Nuclear magnetic resonance
palmar osteochondral disease
Prospective Studies
Science & Technology
Spectrum analysis
Synovial Fluid
Veterinary Sciences
title Metabolomic analysis of synovial fluid from Thoroughbred racehorses diagnosed with palmar osteochondral disease using magnetic resonance imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T05%3A54%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolomic%20analysis%20of%20synovial%20fluid%20from%20Thoroughbred%20racehorses%20diagnosed%20with%20palmar%20osteochondral%20disease%20using%20magnetic%20resonance%20imaging&rft.jtitle=Equine%20veterinary%20journal&rft.au=Graham,%20R.%20J.%20T.%20Y.&rft.date=2020-05&rft.volume=52&rft.issue=3&rft.spage=384&rft.epage=390&rft.pages=384-390&rft.issn=0425-1644&rft.eissn=2042-3306&rft_id=info:doi/10.1111/evj.13199&rft_dat=%3Cproquest_cross%3E2386947433%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2386947433&rft_id=info:pmid/31657070&rfr_iscdi=true